Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0676 CHF | +14.58% | -2.03% | +64.88% |
May. 01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+64.88% | 4.37M | |
-2.10% | 90.02B | |
-0.66% | 39.15B | |
-15.83% | 31.71B | |
+62.42% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-10.32% | 11.18B | |
-45.77% | 10.97B | |
+3.45% | 8.94B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Swiss Court OKs Moratorium Extension for Spexis